Autosomal-dominant Polycystic Kidney Disease: 3 Studies in Brief

Three new studies on ADPKD treatment project long-term impact of tolvaptan; reveal potential in an existing drug class; and, report success in slowing comorbid hepatic disease.  

Source: ConsultantLive - July 8, 2019 Category: Internal Medicine Authors: Andrew D. Bowser Tags: Kidney Disease Source Type: news